Sodium Chloride Inhalation Solution USP 3% w/v: Sodichlor 3% Composition and Clinical Applications

Introduction

SODICHLOR 3% is a sterile hypertonic saline solution containing Sodium Chloride Inhalation Solution USP 3% w/v, formulated to support airway clearance in patients with respiratory conditions. As a therapeutic inhalation solution, sodium chloride inhalation solution USP 3% w/v helps loosen thick mucus in the lungs, making it easier to expel and breathe more freely. It is widely used in clinical settings and at home for diseases like cystic fibrosis, bronchitis, and bronchiolitis.

Mechanism of Action

Sodium chloride inhalation solution USP 3% w/v works by increasing the salt concentration in the respiratory tract. When nebulized and inhaled, the hypertonic solution draws water into the airway surface liquid through osmosis. This process:

• Hydrates airway mucus, making it less viscous

• Improves mucociliary clearance, allowing the lungs to expel trapped particles and pathogens

• Enhances airflow and lung function in conditions with mucus buildup

The result is easier breathing and reduced frequency of airway blockages.

Uses and Indications

SODICHLOR 3% is commonly prescribed for:

• Cystic Fibrosis (CF): To loosen thick secretions in the lungs

• Bronchiolitis in infants and children

• Bronchiectasis and chronic bronchitis

• Post-operative respiratory therapy

• Tracheostomized patients for airway hydration

• Nebulization in general respiratory infections with mucus overproduction

Sodium chloride inhalation solution is particularly helpful in patients who struggle with clearing secretions or are prone to recurrent chest infections.

Efficacy and Clinical Evidence

Multiple studies have demonstrated that sodium chloride inhalation solution USP 3% w/v: :

• Improves mucus clearance significantly in cystic fibrosis and bronchiolitis

• Reduces hospital stay duration in pediatric bronchiolitis cases

• Enhances pulmonary function (FEV1) in chronic lung diseases

• Offers a safe alternative to bronchodilators in some patient populations

SODICHLOR 3% is especially favored in pediatric care for its non-invasive and supportive therapy role.

Side Effects and Safety Profile

Sodium chloride inhalation solution 3% is generally well-tolerated. Mild side effects may include:

• Coughing during or after nebulization

• Throat irritation or dryness

• Slight wheezing in sensitive individuals

• Nasal congestion

Rarely, patients may experience bronchospasm. In such cases, pre-treatment with a bronchodilator may be recommended.

Contraindications and Precautions

Contraindications:

• Hypersensitivity to sodium chloride
  

• Severe airway hyperresponsiveness
  

• Acute asthma exacerbation without bronchodilator cover
  

Precautions:

• Use with caution in infants under 6 months (monitor closely)

• In patients with compromised respiratory function, start under medical supervision

• Avoid use if solution is cloudy or contains visible particles

Drug Interactions

SODICHLOR 3% has minimal interaction with systemic medications. However:

• Use with bronchodilators may be coordinated for smoother inhalation

• Should not be mixed directly with other inhaled drugs in the same nebulizer chamber

• Always consult a physician before combining nebulized therapies

Warnings and Regulatory Status

• SODICHLOR 3% is a prescription medical product for inhalation use

• Should be used only via nebulization under sterile conditions

• Not to be injected or used for IV administration

• Approved for use in many countries under respiratory care protocols

• Ensure sterile storage and proper disposal after use

Patient Advice and Tips

• Use with a jet nebulizer as advised by your doctor

• Always wash hands and equipment before use

• Take slow, deep breaths during nebulization

• If coughing or throat irritation occurs, pause and resume slowly

• Store solution in a cool, dry place away from sunlight

Availability

SODICHLOR 3% is available as single-use vials of sodium chloride inhalation solution USP 3% w/v. Each vial is sterile, preservative-free, and designed for ease of use with standard nebulizers. Manufactured under stringent WHO-GMP standards by Steris Healthcare Pvt Ltd, it is widely distributed across hospitals, pharmacies, and homecare setups.

Frequently Asked Questions : 

1. What is sodium chloride inhalation solution used for?
It is used to loosen mucus in the lungs, aiding in better breathing for conditions like cystic fibrosis, bronchiolitis, and bronchitis.

2. Is 3% sodium chloride safe for babies?
Yes, it is often used in infants with bronchiolitis but should be administered under medical supervision.

3. How many times a day can I use SODICHLOR 3%?
Typically, 2–4 times daily depending on the condition. Always follow your doctor’s instructions.

4. Can I use this with a mesh nebulizer?
Yes, but consult your doctor to ensure compatibility and dosage accuracy.

5. Does it replace bronchodilators?
No. It is a supportive therapy and can be used alongside bronchodilators when needed.

Why Choose Steris Healthcare Pvt Ltd for SODICHLOR 3%?

Steris Healthcare Pvt Ltd is a leading provider of high-quality inhalation and respiratory therapies. Choosing SODICHLOR 3% means:

• Consistent purity and sterility of each vial

• WHO-GMP certified manufacturing process

• Easy-to-use packaging designed for home and hospital use

• Strong clinical credibility and safety assurance

• Nationwide availability and dependable support

With Steris, healthcare providers and patients can trust the quality and effectiveness of every inhalation therapy solution.

Conclusion